News & Events

News

New Publication: Can Real-World Evidence Reliably Fill Evidence Gaps In Accelerated Approval?
Date: October 13, 2026 Journal: Health Affairs Forefront Citation: Neumann PJ, Hatfield GM, Lin P, Manandhar T, Tunis S. Can Real-World Evidence Relia...
Read more October 13, 2026
New Study Sheds Light on QALY and Disability Debate
A new study published in Value in Health, co-authored by CEVR’s Peter Neumann, shows no evidence that the use of quality-adjusted life years (QALYs) d...
Read more September 28, 2026
CEVR Welcomes 2026 CEA Registry Summer Fellows
CEVR Welcomes 2026 CEA Registry Summer Fellows CEVR is thrilled to introduce the 2026 cohort of the Tufts-CEVR CEA Registry Summer Fellowship program,...
Read more July 29, 2026
View All News Items

Events

CEVR Health Policy Seminar with Bill Padula PhD
Learn more
12:00–1:00 on October 27, 2026
The SPEC team is heading to AMCP Nexus
Learn more
October 27–28, 2026
Join us for CEVR's next webinar on "Strengthening post-approval evidence for accelerated approval drugs"
Learn more
1:00–2:00 on October 21, 2026
View All Events

Publications

AMCP Nexus 2026
Variation in step therapy for commercial plan coverage of rheumatoid arthritis therapies
View publication
AMCP Nexus 2026
Do prices and doses differ for initial and follow-on indications? An analysis of multi-indication orphan drugs
View publication
Health Affairs Forefront
Can Real-World Evidence Reliably Fill Evidence Gaps In Accelerated Approval?
View publication
AMCP Nexus 2026
US Commercial Health Plan Step-Therapy Requirements for Ranibizumab Products, 2017–2025
View publication
Health Affairs Forefront
When Negotiated Prices Become The Benchmark: Prior MFPs And The Vanishing Role Of Value
View publication
ISPOR 2026 (Poster Presentation)
Comparative Analysis of Oncology Therapy Approvals in the U.S. and Most Favored Nation Countries
View publication
PharmacoEconomics
Value of Knowing the Risk of Developing a Neurodegenerative Disease: A Discrete Choice Experiment
View publication
JAMA Dermatology
Variation in Coverage of Atopic Dermatitis Therapies Across Commercial Payers
View publication
Journal of Managed Care & Specialty Pharmacy
US commercial health plan use of corticosteroids in step therapy protocols: Frequency and clinical appropriateness
View publication
View All Publications